Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
about
The pericyte: a forgotten cell type with important implications for Alzheimer's disease?A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer diseaseNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersFocused ultrasound-mediated drug delivery through the blood-brain barrier.Development of neuropeptide drugs that cross the blood-brain barrier.Acute stress alters auditory selective attention in humans independent of HPA: a study of evoked potentials.Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrierSmall molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.Involvement of non-neuronal brain cells in AVP-mediated regulation of water space at the cellular, organ, and whole-body level.Brainpeps: the blood-brain barrier peptide database.The impact of acute psychosocial stress on magnetoencephalographic correlates of emotional attention and exogenous visual attention.Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differencesTreatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's diseasePericytes contribute to the disruption of the cerebral endothelial barrier via increasing VEGF expression: implications for stroke.Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?New therapeutic targets in the neurovascular pathway in Alzheimer's disease.Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia.Sink hypothesis and therapeutic strategies for attenuating Abeta levels.Age-associated physiological and pathological changes at the blood-brain barrier: A review.Brain metabolism in health, aging, and neurodegeneration.Peptides and the blood-brain barrier: the status of our understanding.The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system.Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivoMultiple sites of vasopressin synthesis in the injured brain.Vasopressin uptake by hypothalamopituitary axis and pineal gland in guinea pigs.The role of peripheral vasopressin 1A and oxytocin receptors on the subcutaneous vasopressin antinociceptive effects.Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.
P2860
Q26852369-CBF22BDE-4E18-4577-82A1-758FB09EDA52Q28261647-1527F8B0-A60A-49C3-84C7-49F3F4547FB3Q29615839-C906A4DF-EE09-47F1-85B4-26A612327E8DQ30394357-2725B395-8F88-4035-A498-A843E484C0D9Q33569277-9D0FD1A4-4040-471B-9A6B-F6E6BE7931D5Q33869173-E3FE1D45-A60D-4CF2-B8A5-FB4581D542E3Q33954036-2A16E23F-1383-4578-B709-BAAD53F15CD6Q33985125-5F719D7D-CB70-4492-A2CE-830B7CCA3A1EQ34078830-20FF25DB-EB5D-4D61-9AFB-EFF8B1C67785Q34243408-1641E980-1BD9-4517-8F18-B96A47F31D17Q34305092-903245F0-98A8-4295-AD40-A3ECA090065CQ34608061-D196AAA8-B583-40F8-BD87-79342D9B6814Q34734936-DD068B1D-1ACA-4E90-86B1-1D30433B8BB1Q35559895-07A8DDD2-C57B-431C-A67E-949D6E36C54EQ35605557-2F4504F4-6E11-452A-96DD-BCAB8F0FCAA1Q35649716-E7213F34-64E9-4F39-A9DF-F662E99DC04FQ36876341-80297A46-E084-4297-B35B-BAD6EA6412B0Q37151644-8D1A4A68-E9DA-4E27-9023-FE21A1EFA782Q37844327-9491F915-A094-4C85-8049-86230B1AE170Q39005977-C914E398-EA83-4BF6-917F-43EFFFD48EADQ39259780-6AD7E0B8-83EF-4846-B44F-1B0387C745A5Q40577778-6F5DD37C-5104-450D-9E49-D5FA09C6F7B9Q41232282-B1864B2F-2AB6-438B-BE05-BA7D4605096AQ41627968-70B9B04F-9E49-42FC-9952-4032165691F2Q41929412-EB8B1F18-F7C1-4C89-B6CA-402B3A28413DQ46354624-00E7BA39-27CB-4FCE-9487-D82ED3231E55Q47728886-79C92F9B-80AB-49F6-A4EE-6D536F6C8A4BQ48302755-6A274129-6568-4C38-ACFE-5B641A040F35
P2860
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@ast
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@en
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@nl
type
label
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@ast
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@en
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@nl
prefLabel
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@ast
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@en
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@nl
P2093
P1476
Kinetics of arginine-vasopressin uptake at the blood-brain barrier.
@en
P2093
P304
P356
10.1016/0005-2736(90)90097-8
P407
P577
1990-06-01T00:00:00Z